<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The present study was conducted to investigate whether <z:chebi fb="0" ids="36281">caffeic acid</z:chebi> phenethyl <z:chebi fb="21" ids="35701">ester</z:chebi> (CAPE), an active component of propolis extract, has a protective effect on brain injury after focal permanent <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo>, and to determine the possible <z:chebi fb="11" ids="22586">antioxidant</z:chebi> mechanisms </plain></SENT>
<SENT sid="1" pm="."><plain><z:e sem="disease" ids="C0007785" disease_type="Disease or Syndrome" abbrv="">Cerebral infarction</z:e> in adult male New Zealand rabbits was induced by microsurgical procedures producing right focal permanent middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> (pMCAO) </plain></SENT>
<SENT sid="2" pm="."><plain>CAPE was administered to the treatment group after pMCAO at a dose of 10 micromol kg(-1) once a day intraperitoneally for 7 days </plain></SENT>
<SENT sid="3" pm="."><plain>Neurological deficits were evaluated, using a modified six-point scale </plain></SENT>
<SENT sid="4" pm="."><plain>Spectrophotometric assay was used to determine the contents of malondialdehyde (<z:chebi fb="14" ids="32506">MDA</z:chebi>), <z:chebi fb="0" ids="16856">glutathione</z:chebi> (GSH), catalase (CAT), nitric <z:chebi fb="177" ids="25741,29356">oxide</z:chebi> (NO) and <z:chebi fb="1" ids="15318,17712">xanthine</z:chebi> oxidase (XO) </plain></SENT>
<SENT sid="5" pm="."><plain>In the ipsilateral hemisphere, the <z:mpath ids='MPATH_124'>infarct</z:mpath> volume of the brain was assessed in brain slices stained with heamatoxylen and eosin </plain></SENT>
<SENT sid="6" pm="."><plain>The results showed that treatment with CAPE significantly reduced the percentage of infarction in the ipsilateral hemisphere compared with the <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> group </plain></SENT>
<SENT sid="7" pm="."><plain>CAPE treatment significantly attenuated the elevation of plasma <z:chebi fb="14" ids="32506">MDA</z:chebi>, CAT and XO content (p&lt;0.05), whereas it significantly increased the levels of plasma GSH and NO (p&lt;0.05) </plain></SENT>
<SENT sid="8" pm="."><plain>Therefore, <z:hpo ids='HP_0011011'>subacute</z:hpo> CAPE administration plays a protective role in focal pMCAO due to attenuation of <z:chebi fb="23" ids="18059">lipid</z:chebi> peroxidation and its <z:chebi fb="11" ids="22586">antioxidant</z:chebi> activity </plain></SENT>
<SENT sid="9" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> of these findings suggest that CAPE provides neuroprotection against <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> injury through its <z:chebi fb="11" ids="22586">antioxidant</z:chebi> action </plain></SENT>
</text></document>